US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals

Watchlist
  • 17.880
  • +0.270+1.53%
Close Apr 26 16:00 ET
  • 17.880
  • 0.0000.00%
Post 16:13 ET
1.27BMarket Cap137.54P/E (TTM)

Kiniksa Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
193.44%3.99M
129.05%13.3M
137.36%4.33M
-72.63%16.99M
52.16%-3.74M
88.42%-4.27M
104.60%5.81M
38.70%-11.58M
317.66%62.05M
79.83%-7.82M
Net income from continuing operations
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
833.67%224.09M
51.93%-19.98M
Operating gains losses
----
442.42%179K
-60.00%4K
--0
--0
--175K
-67.96%33K
--10K
---11K
----
Depreciation and amortization
-21.81%466K
-2.54%2.34M
-10.30%540K
22.31%603K
-7.53%602K
-9.15%596K
2.00%2.4M
-9.88%602K
-25.08%493K
-9.21%651K
Deferred tax
305.29%4.37M
81.78%-33.79M
-7,487.64%-25.71M
105.54%10.29M
---19.44M
--1.08M
-1,686,418.18%-185.5M
3,063.64%348K
---185.84M
--0
Other non cash items
-7.37%779K
0.43%3.05M
-6.47%737K
-8.42%707K
3.08%769K
14.42%841K
15.58%3.04M
7.07%788K
9.97%772K
24.33%746K
Change In working capital
3,199.23%8.58M
105.98%1.35M
83.46%-3.96M
-33.76%11.01M
-250.05%-5.96M
101.35%260K
-3,376.49%-22.58M
-345.61%-23.95M
400.23%16.63M
189.57%3.97M
-Change in receivables
-59.11%5.27M
94.18%-950K
-99.03%-18.23M
744.85%21.61M
-179.63%-17.23M
150.65%12.89M
-317.67%-16.33M
-1,234.84%-9.16M
-397.92%-3.35M
947.98%21.63M
-Change in inventory
310.51%3.84M
46.87%-9.52M
20.62%-5.54M
-130.69%-1.63M
92.04%-533K
80.88%-1.83M
-387.73%-17.92M
-461.37%-6.98M
583.23%5.3M
-4.89%-6.69M
-Change in prepaid assets
242.37%3.75M
-83.18%-7.07M
81.70%8.85M
-971.80%-13.99M
120.32%709K
33.01%-2.63M
-231.18%-3.86M
155.27%4.87M
-206.10%-1.31M
-477.65%-3.49M
-Change in payables and accrued expense
103.63%623K
644.49%17.29M
374.42%12.52M
768.41%7.97M
304.10%13.95M
-406.34%-17.16M
-80.16%2.32M
-74.36%2.64M
118.37%918K
-230.04%-6.84M
-Change in other current assets
-202.88%-3.36M
72.72%4.58M
630.57%1.41M
--0
-155.21%-90K
18.62%3.27M
180.82%2.65M
88.09%-265K
100.13%1K
439.58%163K
-Change in other current liabilities
-32.98%-1.25M
-125.45%-3.24M
-2.85%-793K
-191.27%-711K
1.12%-795K
-46.88%-943K
53.43%-1.44M
47.48%-771K
171.21%779K
-637.61%-804K
-Change in other working capital
-104.42%-294K
-97.83%261K
84.78%-2.18M
-115.70%-2.24M
---1.98M
-44.52%6.66M
--12M
---14.29M
--14.29M
--0
Cash from discontinued investing activities
Operating cash flow
193.44%3.99M
129.05%13.3M
137.36%4.33M
-72.63%16.99M
52.16%-3.74M
88.42%-4.27M
104.60%5.81M
38.70%-11.58M
317.66%62.05M
79.83%-7.82M
Investing cash flow
Cash flow from continuing investing activities
167.31%25.52M
-265.90%-29.56M
65.09%-14.89M
-164.48%-12.28M
-7.14%35.53M
-66.88%-37.92M
-106.28%-8.08M
14.75%-42.66M
-60.21%19.04M
-55.50%38.27M
Net PPE purchase and sale
-250.00%-84K
-828.57%-130K
-233.33%-56K
50.00%-16K
-41.67%-34K
---24K
96.63%-14K
116.73%42K
37.25%-32K
59.32%-24K
Net intangibles purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
167.57%25.61M
-264.92%-29.43M
65.25%-14.84M
-164.29%-12.26M
-7.11%35.57M
-66.77%-37.9M
-105.41%-8.06M
14.24%-42.7M
-60.18%19.07M
-55.50%38.29M
Cash from discontinued investing activities
Investing cash flow
167.31%25.52M
-265.90%-29.56M
65.09%-14.89M
-164.48%-12.28M
-7.14%35.53M
-66.88%-37.92M
-106.28%-8.08M
14.75%-42.66M
-60.21%19.04M
-55.50%38.27M
Financing cash flow
Cash flow from continuing financing activities
3,914.44%3.61M
-40.58%1.5M
-41.60%695K
52.91%552K
-70.85%158K
-78.72%90K
-57.25%2.52M
-1.82%1.19M
-86.53%361K
-38.90%542K
Net common stock issuance
9.29%-381K
-144.84%-2.21M
-162.00%-262K
-431.25%-1.11M
-1,645.83%-419K
26.19%-420K
---901K
97.86%-100K
-104.45%-208K
---24K
Proceeds from stock option exercised by employees
683.14%3.99M
8.31%3.7M
-25.81%957K
191.21%1.66M
1.94%577K
-48.59%510K
-41.94%3.42M
--1.29M
--569K
-36.19%566K
Cash from discontinued financing activities
Financing cash flow
3,914.44%3.61M
-40.58%1.5M
-41.60%695K
52.91%552K
-70.85%158K
-78.72%90K
-57.25%2.52M
-1.82%1.19M
-86.53%361K
-38.90%542K
Net cash flow
Beginning cash position
-12.03%107.95M
0.20%122.72M
-32.96%117.83M
19.36%112.57M
27.31%80.62M
0.20%122.72M
7.20%122.47M
-7.58%175.76M
-43.92%94.31M
-47.26%63.32M
Current changes in cash
178.68%33.12M
-6,124.90%-14.76M
81.39%-9.87M
-93.54%5.26M
3.12%31.95M
28.83%-42.1M
-97.02%245K
21.66%-53.05M
269.91%81.45M
-35.58%30.98M
End cash Position
75.00%141.08M
-12.03%107.95M
-12.03%107.95M
-32.96%117.83M
19.36%112.57M
27.31%80.62M
0.20%122.72M
0.20%122.72M
-7.58%175.76M
-43.92%94.31M
Free cash flow
190.96%3.9M
130.99%13.17M
136.98%4.27M
-72.64%16.97M
52.42%-3.78M
88.35%-4.29M
103.89%5.7M
39.67%-11.54M
317.20%62.03M
79.56%-7.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 193.44%3.99M129.05%13.3M137.36%4.33M-72.63%16.99M52.16%-3.74M88.42%-4.27M104.60%5.81M38.70%-11.58M317.66%62.05M79.83%-7.82M
Net income from continuing operations -44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M833.67%224.09M51.93%-19.98M
Operating gains losses ----442.42%179K-60.00%4K--0--0--175K-67.96%33K--10K---11K----
Depreciation and amortization -21.81%466K-2.54%2.34M-10.30%540K22.31%603K-7.53%602K-9.15%596K2.00%2.4M-9.88%602K-25.08%493K-9.21%651K
Deferred tax 305.29%4.37M81.78%-33.79M-7,487.64%-25.71M105.54%10.29M---19.44M--1.08M-1,686,418.18%-185.5M3,063.64%348K---185.84M--0
Other non cash items -7.37%779K0.43%3.05M-6.47%737K-8.42%707K3.08%769K14.42%841K15.58%3.04M7.07%788K9.97%772K24.33%746K
Change In working capital 3,199.23%8.58M105.98%1.35M83.46%-3.96M-33.76%11.01M-250.05%-5.96M101.35%260K-3,376.49%-22.58M-345.61%-23.95M400.23%16.63M189.57%3.97M
-Change in receivables -59.11%5.27M94.18%-950K-99.03%-18.23M744.85%21.61M-179.63%-17.23M150.65%12.89M-317.67%-16.33M-1,234.84%-9.16M-397.92%-3.35M947.98%21.63M
-Change in inventory 310.51%3.84M46.87%-9.52M20.62%-5.54M-130.69%-1.63M92.04%-533K80.88%-1.83M-387.73%-17.92M-461.37%-6.98M583.23%5.3M-4.89%-6.69M
-Change in prepaid assets 242.37%3.75M-83.18%-7.07M81.70%8.85M-971.80%-13.99M120.32%709K33.01%-2.63M-231.18%-3.86M155.27%4.87M-206.10%-1.31M-477.65%-3.49M
-Change in payables and accrued expense 103.63%623K644.49%17.29M374.42%12.52M768.41%7.97M304.10%13.95M-406.34%-17.16M-80.16%2.32M-74.36%2.64M118.37%918K-230.04%-6.84M
-Change in other current assets -202.88%-3.36M72.72%4.58M630.57%1.41M--0-155.21%-90K18.62%3.27M180.82%2.65M88.09%-265K100.13%1K439.58%163K
-Change in other current liabilities -32.98%-1.25M-125.45%-3.24M-2.85%-793K-191.27%-711K1.12%-795K-46.88%-943K53.43%-1.44M47.48%-771K171.21%779K-637.61%-804K
-Change in other working capital -104.42%-294K-97.83%261K84.78%-2.18M-115.70%-2.24M---1.98M-44.52%6.66M--12M---14.29M--14.29M--0
Cash from discontinued investing activities
Operating cash flow 193.44%3.99M129.05%13.3M137.36%4.33M-72.63%16.99M52.16%-3.74M88.42%-4.27M104.60%5.81M38.70%-11.58M317.66%62.05M79.83%-7.82M
Investing cash flow
Cash flow from continuing investing activities 167.31%25.52M-265.90%-29.56M65.09%-14.89M-164.48%-12.28M-7.14%35.53M-66.88%-37.92M-106.28%-8.08M14.75%-42.66M-60.21%19.04M-55.50%38.27M
Net PPE purchase and sale -250.00%-84K-828.57%-130K-233.33%-56K50.00%-16K-41.67%-34K---24K96.63%-14K116.73%42K37.25%-32K59.32%-24K
Net intangibles purchase and sale ------0------------------0------------
Net investment purchase and sale 167.57%25.61M-264.92%-29.43M65.25%-14.84M-164.29%-12.26M-7.11%35.57M-66.77%-37.9M-105.41%-8.06M14.24%-42.7M-60.18%19.07M-55.50%38.29M
Cash from discontinued investing activities
Investing cash flow 167.31%25.52M-265.90%-29.56M65.09%-14.89M-164.48%-12.28M-7.14%35.53M-66.88%-37.92M-106.28%-8.08M14.75%-42.66M-60.21%19.04M-55.50%38.27M
Financing cash flow
Cash flow from continuing financing activities 3,914.44%3.61M-40.58%1.5M-41.60%695K52.91%552K-70.85%158K-78.72%90K-57.25%2.52M-1.82%1.19M-86.53%361K-38.90%542K
Net common stock issuance 9.29%-381K-144.84%-2.21M-162.00%-262K-431.25%-1.11M-1,645.83%-419K26.19%-420K---901K97.86%-100K-104.45%-208K---24K
Proceeds from stock option exercised by employees 683.14%3.99M8.31%3.7M-25.81%957K191.21%1.66M1.94%577K-48.59%510K-41.94%3.42M--1.29M--569K-36.19%566K
Cash from discontinued financing activities
Financing cash flow 3,914.44%3.61M-40.58%1.5M-41.60%695K52.91%552K-70.85%158K-78.72%90K-57.25%2.52M-1.82%1.19M-86.53%361K-38.90%542K
Net cash flow
Beginning cash position -12.03%107.95M0.20%122.72M-32.96%117.83M19.36%112.57M27.31%80.62M0.20%122.72M7.20%122.47M-7.58%175.76M-43.92%94.31M-47.26%63.32M
Current changes in cash 178.68%33.12M-6,124.90%-14.76M81.39%-9.87M-93.54%5.26M3.12%31.95M28.83%-42.1M-97.02%245K21.66%-53.05M269.91%81.45M-35.58%30.98M
End cash Position 75.00%141.08M-12.03%107.95M-12.03%107.95M-32.96%117.83M19.36%112.57M27.31%80.62M0.20%122.72M0.20%122.72M-7.58%175.76M-43.92%94.31M
Free cash flow 190.96%3.9M130.99%13.17M136.98%4.27M-72.64%16.97M52.42%-3.78M88.35%-4.29M103.89%5.7M39.67%-11.54M317.20%62.03M79.56%-7.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg